Cardiology News and Research

Latest Cardiology News and Research

U.S. FDA posts public health communication about metal-on-metal hip implants use in THA

The U.S. Food and Drug Administration posted a public health communication this week about metal-on-metal hip components to notify the public of the concerns on the use of metal-on-metal hip components used in total hip arthroplasty.

18 Feb 2011

CCS Atrial Fibrillation Guidelines help Canadian physicians recognize and treat heart conditions

The Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010 help Canadian physicians better recognize and treat a common heart condition that affects about 250,000 Canadians.

18 Feb 2011

Scottsdale Healthcare implants MRI-safe pacemaker

Scottsdale Healthcare Shea Medical Center is the first hospital in the southwestern United States to implant an MRI-safe pacemaker, a major technological breakthrough for patients who need MRI diagnostic scans, which can damage older style pacemakers or cause serious health complications.

18 Feb 2011

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery according to a study by researchers at Rush University Medical Center.

18 Feb 2011

Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor.

18 Feb 2011

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell Technologies,™ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStent™ Drug-Eluting Coronary Stent System (MiStent DES).

18 Feb 2011

MU study finds behavior strategies increase physical activity levels in healthy adults

Most people know that exercise is important to maintain and improve health; however, sedentary lifestyles and obesity rates are at all-time highs and have become major national issues.

18 Feb 2011

Research: Urban children spend more time playing outdoors

Young children living in urban public housing spend more time playing outdoors than other urban children, according to researchers at Rice University, Columbia University and Princeton University.

18 Feb 2011

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

Approximately nine million Americans over the age of 50 are living with a disease that affects their legs and raises their risk of having a heart attack. Unfortunately, many with the disease do not even know they have it. February is Heart Month, and the Vascular Disease Foundation and its P.A.D. Coalition are urging Americans to listen to their legs and be alert to the signs of peripheral arterial disease, or P.A.D.

18 Feb 2011

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.

18 Feb 2011

Statin drug may help prevent blindness in diabetics

New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes.

17 Feb 2011

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

Astellas Pharma Canada, Inc. has announced that it has received approval from Health Canada for a new indication for its topical eczema therapy, Protopic® (tacrolimus ointment 0.03% and 0.1%). The new indication means that tacrolimus ointment can be prescribed for maintenance therapy to prevent flares and prolong flare free intervals in patients with moderate to severe atopic dermatitis (commonly called eczema).

17 Feb 2011

West Virginia receives $186,000 AstraZeneca grant to expand Cardiovascular Health program

The AstraZeneca HealthCare Foundation program, Connections for Cardiovascular Health, today announced a grant of more than $186,000 to West Virginia Health Right, Inc. in Charleston to expand the Pathways to Cardiovascular Health program.

17 Feb 2011

New study: Fast food meal consumption can affect inflammatory responses in blood vessels

The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels, suggests new research at UC Davis.

17 Feb 2011

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

Doctor speaks on health effects of chronic inflammation

If your body is in a chronic state of inflammation, it can have serious effects on your cellular health, and has been linked to degenerative diseases including cancer, heart disease, diabetes, Alzheimer's and many others. Luckily, there are numerous ways to control chronic inflammation naturally and promote overall health in the process.

17 Feb 2011

Research!America applauds President Obama for prioritizing R&D in FY2012 budget proposal

Research!America's board chair, former Congressman John Edward Porter, and president, Mary Woolley, thanked President Obama for prioritizing medical, health and scientific research in his FY2012 budget proposal.

17 Feb 2011

Third trimester amniotic fluid a reliable source of stem cells

In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.

17 Feb 2011

PMC to sponsor UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.

17 Feb 2011

Continued smoking during radiation treatment for head and neck cancer affects prognosis

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

17 Feb 2011

Cardiology News and Research

Latest Cardiology News and Research

U.S. FDA posts public health communication about metal-on-metal hip implants use in THA

CCS Atrial Fibrillation Guidelines help Canadian physicians recognize and treat heart conditions

Scottsdale Healthcare implants MRI-safe pacemaker

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

MU study finds behavior strategies increase physical activity levels in healthy adults

Research: Urban children spend more time playing outdoors

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

Statin drug may help prevent blindness in diabetics

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

West Virginia receives $186,000 AstraZeneca grant to expand Cardiovascular Health program

New study: Fast food meal consumption can affect inflammatory responses in blood vessels

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Doctor speaks on health effects of chronic inflammation

Research!America applauds President Obama for prioritizing R&D in FY2012 budget proposal

Third trimester amniotic fluid a reliable source of stem cells

PMC to sponsor UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

Continued smoking during radiation treatment for head and neck cancer affects prognosis

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cardiology News and Research

Latest Cardiology News and Research

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in